The Listed Companies On The Science And Technology Innovation Board Have Gathered In "Double Hundred" New Generation Information Technology, Biological Medicine And Other Industries, With A Market Value Of More Than 3.6 Trillion

On December 7, with the landing of Xinzhi software in a share market, the science and technology innovation board, which has been running for nearly a year and a half, has 200 listed companies.

According to the statistical analysis of researchers from the 21st Century Capital Research Institute, these 200 companies have gathered the first unprofitable company, red chip company, CDR, and a series of giant companies on the subdivision track. Compared with the "hundred" period, the industry agglomeration effect of the science and technology innovation board is more significant, the science and technology innovation attribute is prominent, and the inclusiveness and diversity of enterprises are also expanded.

Kechuang has realized the financing of 2876 million yuan in nearly one and a half years, and the most important one that has been listed in Kechuang board is more than one and a half billion yuan. These investments are gradually transformed into the driving force for the development of science and technology innovation enterprises, which will also bring more help to the industry in the future, and further improve the capital formation mechanism supporting innovation.

Distinctive characteristics of industry agglomeration

Xinzhi software, the 200th company of the science and technology innovation board, is a software and information technology service provider, focusing on providing general informatization solutions based on their own products for financial institutions. Looking at the whole science and technology innovation board, the industries of listed companies are also highly concentrated in high-tech industries and strategic emerging industries.

Among the 200 companies, the new generation of information technology (including integrated circuit) and biomedicine accounted for 55% of the total, accounting for 65 and 45 respectively. There were 42, 25 and 23 high-end equipment, new materials and energy conservation and environmental protection respectively.

In particular, the high-end medical equipment, integrated circuit, biological medicine and other industries have attracted a number of enterprises with key core technology and outstanding scientific and technological innovation ability to choose to be listed on the science and technology innovation board.

From a regional perspective, the Yangtze River Delta has become a cluster of science and Technology Innovation Board companies. The top five provinces / municipalities directly under the central government in terms of the number of science and technology innovation companies are 39 in Jiangsu Province, 33 in Beijing, 35 in Shanghai, 27 in Guangdong Province and 16 in Zhejiang Province.

On March 29, this year, Guangyun technology, an e-commerce SaaS enterprise, landed on A-share market, becoming the 100th listed enterprise in the science and technology innovation board. If this is the dividing line, more than eight months have passed. Compared with the "hundred schools period", there are some new changes in the science and technology innovation board.

The reporter of 21st century economic report found that the industrial agglomeration effect of integrated circuit, biological medicine and other industries of science and technology innovation board was further obvious. The number of IC companies has increased from 13 to 23, forming a complete industrial cluster upstream and downstream of the industrial chain. The number of biomedical companies increased from 25 to 45, covering the fields of biopharmaceuticals, chemical pharmaceuticals, in vitro diagnostics, medical materials, etc.

At the same time, the attraction of science and technology innovation board to leading enterprises has been continuously improved. After the "full hundred" of the science and technology innovation board, the leading enterprises such as SMIC international, Junshi biology, Qianxin and other leading enterprises have officially boarded the science and technology innovation board, forming a good demonstration effect.

During the period when the science and technology innovation board is moving towards "double hundred", the tolerance of listed enterprises has also been further improved.

Among the 200 enterprises, more than 80% (167) chose the first set of listing standards, 10 for the second, 1 for the third, 15 for the fourth and 7 for the fifth. Compared with the "hundred" period, there were 16 unprofitable listed companies on the science and technology innovation board, and they were no longer patents of biological medicine. There were also companies "testing water" in integrated circuit, network security and other industries. Moreover, CDR has made a "zero breakthrough", and No. 9 company has become the first listed company to issue CDR on the science and technology innovation board.

287.6 billion capital injected into industry

Recently, the chairman of China Securities Regulatory Commission (CSRC), Yi Huiman, wrote an article entitled "improving the proportion of direct financing" and "improving the multi-level capital market system with Chinese characteristics and enhancing the inclusiveness of direct financing. The key to increase the proportion of direct financing is to form a multi-level capital market system that adapts to the differentiated financing needs of enterprises of different types and stages of development, and enhance the universality of services.

As for the science and technology innovation board, the original intention of setting up the science and technology innovation board is to enhance the inclusiveness of the capital market, better serve the enterprises with core technology, good development prospects and public praise, and promote the transformation of scientific and technological achievements.

According to the data collected by the 21st century economic report, 200 science and technology innovation companies that have been listed have raised 287.658 billion yuan. Among them, SMIC international and China Communications have raised more than 10 billion yuan.

A person in the industry commented that the implementation of the registration system on the science and technology innovation board has comprehensively improved the efficiency of equity financing, which has formed a powerful supplement to the main board of Shanghai and Shenzhen. The function and financing efficiency of the science and technology innovation board have been recognized by the market, and the range distribution of fund-raising scale of a single enterprise is similar to that of the main board.

For the listed science and technology innovation enterprises, the total financing amount of more than 200 billion yuan is not an ice cold number. Behind the one-off financing is the power source for Chinese science and technology innovation enterprises to absorb "living water" and fully grow.

Youkede is the first "same share with different rights" listed company on the science and technology innovation board. Ji Xinhua, the founder and CEO of the company, said in an interview recently, "the science and technology innovation board has given many technology companies financial wings, and the scientific and technological innovation board has given us an opportunity to make more infrastructure and temporarily incapable (companies) to PK with giants and gradually grow up."

Judging from the performance of the listed companies, 200 Sci-tech Innovation Board companies have lived up to expectations.

In the first three quarters of this year, the overall operating performance maintained a steady and rising trend. The overall revenue and profit achieved double growth, with a total operating revenue of 209.290 billion yuan, a year-on-year increase of 15.59%, and a total net profit of 24.833 billion yuan, a year-on-year increase of 64.15%. 176 companies were profitable. 145 companies achieved revenue growth, 9 companies doubled revenue; 130 companies achieved net profit growth, 30% of the company's net profit growth was more than 50%.

It is worth mentioning that the "hard technology" oriented science and Technology Innovation Board companies continue to maintain high-intensity R & D investment in the face of complex external environment. According to the data, in the first three quarters of this year, the average R & D investment of 200 science and Technology Innovation Board companies accounted for 15.63% (excluding the companies adopting the fifth set of indicators), with a year-on-year increase of 0.5 percentage points. Among them, nearly 60% of the companies increased their R & D investment intensity, and 38 companies' R & D investment accounted for more than 20% of the operating revenue.

From the perspective of market value, the science and technology innovation board is also growing. As of December 7, the total market value of 200 companies has exceeded 3.6 trillion yuan. Among them, SMIC international, Jinshan office and voice holdings have a total market value of more than 100 billion yuan, and 78 companies have a market value of 10 billion yuan.